SARS-Cov-2 spike protein vaccine induced strong antibody and T cell responses in murine model VANCOUVER, BC, Oct. 8, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that a poster highlighting its preclinical data...